Progression of pure neural leprosy towards borderline lepromatous leprosy
DOI:
https://doi.org/10.66344/jpad.v33i2.2088Abstract
Pure neural leprosy (PNL) is characterized by the absence of skin lesions and negative slit skin smear, however, several studies found that up to 35% cases will progress to visible skin lesion. A 62-year-old man came with chief complaint of facial edema, wound and deformities. The nerve impairment and deformities started progressively seven years ago followed by the emergence of skin lesion recently. Clinical examination revealed madarosis, earlobe infiltrate, punched-out lesion on the face, hypopigmentation on the trunk and extremities with sensory impairment, nerve enlargement alongside sensory and motor deterioration, claw hand, drop foot and resorption of phalanges. The slit skin smear revealed bacterial index (BI) +4 and morphological index (MI) 15%. Histopathological examination revealed periadenexal granulomas consisting of foamy macrophages, histiocytes, epithelioid cells, with BI +5 on Fite-Faraco stain. This case represents progression of PNL towards Borderline Lepromatous (BL) leprosy with type I reaction (T1R) and second-degree deformities. Neuritis and emergence of new lesion on reaction episodes often lead to confirmation of diagnosis in PNL cases. Another hypothesis regarding silent neuropathy explained a progressive nerve damage without any preceding reactions that may arise on treated and untreated cases resulting in extensive deformities. All leprosy cases probably pass through a neuritic phase before the development of skin lesions either following reaction episodes or indicate the natural progression of the disease. Any delay in diagnosis and treatment potentially lead to further deformities and transmission.
References
1. Walker SL, Lockwood DNJ. Leprosy type 1 (reversal) reactions and their management. Lepr Rev. 2008;79:372–86.
2. Kumar B., Dogra S., Case Definition and Clinical Types of Leprosy. (2017). IAL Textbook of Leprosy Second edition. New Delhi: Jaypee Brothers Medical Publishers.
3. Suneetha, S., Sigamoni, A., Kurian, N., Chacko, C. J. G. The development of cutaneous lesions during follow-up of patients with primary neuritic leprosy. Int J Dermatol. 2005;44(3):224–9.
4. Rao PN, Suneetha S. Pure neuritic leprosy: Current status and relevance. Indian J Dermatol Venereol Leprol. 2006;82(3):252-61.
5. Pai, V., et al. Interesting and unusual clinical presentations in leprosy at a referral center. Indian Dermatol Online J. 2013;4(4);273.
6. Dinkes Rembang. Data Prevalensi Kusta. Rembang: DKK Rembang. 2016.
7. Mishra B, et al.. Neuritic leprosy: further progression and significance. Acta Leprol. 1995;9(4):187-94.
8. Jena S, Mishra S, Mohanty G. Silent Neuropathy in Leprosy. Indian J Dermatol Venereol Leprol. 2002:68;84-5.
9. Shetty PV., Pathomechanisms of Nerve Damage. IAL Textbook of Leprosy Second edition. New Delhi: Jaypee Brothers Medical Publishers. 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Aidha Juniar Permatasari Hartono, Hardyanto Soebono
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
